Amplexd Therapeutics develops topical treatments for HPV-induced cervical dysplasia, aiming to improve patient outcomes.
Amplexd Therapeutics has raised $2.0M in total funding. The most recent round was Seed. The last funding was announced in May 2024.
Amplexd Therapeutics is headquartered in Gaithersburg, United States.
Amplexd Therapeutics develops topical treatments for HPV-induced cervical dysplasia, aiming to improve patient outcomes.
Amplexd Therapeutics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Amplexd Therapeutics — Funding & Investors." VCBacked, May 19, 2024, https://www.vcbacked.co/company/amplexd-therapeutics. Accessed August 14, 2026.
VCBacked. (2024). Amplexd Therapeutics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/amplexd-therapeutics
{{cite web |title=Amplexd Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/amplexd-therapeutics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated